US Broker Ratings

Centene Corporation (CNC) Stock Analysis: Understanding the Healthcare Giant’s Current Valuation and Investor Sentiment

Centene Corporation (NYSE: CNC), a formidable player in the healthcare plans industry, is currently in the spotlight for investors seeking to navigate the complexities of the..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unveiling a Potential 212.93% Upside

For investors with an eye for opportunities in the biotechnology sector, Vaxcyte, Inc. (NASDAQ: PCVX) presents an intriguing prospect. Despite the company’s current share price of..

Viatris Inc. (VTRS) Stock Analysis: Exploring a Potential 20% Upside Amid High Dividend Yield

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, has caught the attention of investors with its enticing potential upside of 20.05%, according to..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 31.96% Potential Upside Amid Strong Buy Ratings

Intuitive Surgical, Inc. (NASDAQ: ISRG), a prominent leader in the healthcare sector’s Medical Instruments & Supplies industry, is drawing significant attention from investors. With a robust..

Alkermes plc (ALKS) Stock Analysis: Exploring a 49.54% Potential Upside in the Healthcare Sector

Alkermes plc (NASDAQ: ALKS), an Irish biopharmaceutical company, stands out in the healthcare sector with a promising potential upside of 49.54%, capturing the attention of investors..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a Remarkable 71.84% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) is a biotechnology firm that is attracting significant attention within the healthcare sector. Headquartered in Redwood City, California, this clinical-stage precision..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotech Leader with Strong Buy Ratings and Strategic Collaborations

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a trailblazer in the biotechnology sector, has been making waves with its innovative therapeutic solutions based on ribonucleic acid interference (RNAi)...

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring Growth Potential Amid 1,353.80% Revenue Surge

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a key player in the biotechnology sector, is attracting significant attention from investors, thanks to its remarkable revenue growth of 1,353.80%...

Abbott Laboratories (ABT) Stock Analysis: Unlocking a 6.87% Potential Upside with Robust Growth and Dividend Stability

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector and a leading player in the medical devices industry, commands a significant presence with a market..

Natera, Inc. (NTRA) Stock Analysis: Evaluating the 18.92% Upside Potential in Healthcare Diagnostics

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare diagnostics sector, offers a suite of advanced molecular testing services that are gaining significant traction worldwide...

Regencell Bioscience Holdings L (RGC) Stock Analysis: Unveiling the Potential in Traditional Chinese Medicine

Regencell Bioscience Holdings L (RGC) stands as a compelling entity within the healthcare sector, specifically nestled in the niche of drug manufacturing, both specialty and generic...

GSK plc (GSK) Investor Outlook: Navigating a 3.89% Potential Upside with Strong Dividend Yield

In the dynamic realm of healthcare, GSK plc (NYSE: GSK) stands as a formidable titan, commanding a market capitalization of $80.2 billion. As a stalwart in..

Elanco Animal Health (ELAN) Stock Analysis: Is the Veterinary Leader’s Growth Sustainable?

Elanco Animal Health Incorporated (NYSE: ELAN), a stalwart in the healthcare sector, is a pivotal player in the Drug Manufacturers – Specialty & Generic industry. With..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 14% Potential Upside Amidst Healthcare Innovation

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector, continues to garner attention from investors with its robust portfolio in the medical devices industry...

Nuvalent, Inc. (NUVL) Stock Analysis: Unlocking a 43% Potential Upside in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL) has emerged as a notable player within the biotechnology industry, operating at the cutting edge of cancer treatment development. With a market..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: A 51% Upside Potential with Strong Buy Ratings

Axsome Therapeutics, Inc. (NASDAQ: AXSM) stands out as a compelling investment opportunity within the biotechnology sector, particularly for those interested in the healthcare landscape. With its..

Sanofi (SNY) Investor Outlook: Potential 35% Upside Amid Strong Dividend Yield

Sanofi (SNY), a major player in the global healthcare sector, is capturing investor attention with a compelling mix of potential stock growth and robust dividend yield...

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Navigating a 30% Potential Upside Amidst Healthcare Sector Dynamics

Investors looking at Teva Pharmaceutical Industries (NYSE: TEVA) might find themselves intrigued by the company’s current positioning within the healthcare sector, particularly the drug manufacturing industry..

Exact Sciences Corporation (EXAS) Stock Analysis: Uncovering a 20.68% Potential Upside in the Healthcare Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS) has been making waves in the healthcare diagnostics sector with its innovative cancer screening solutions. As a pioneering player in diagnostics..

Encompass Health Corporation (EHC) Stock Analysis: Strong Buy Ratings and 8.46% Potential Upside

Investors seeking opportunities in the healthcare sector may find Encompass Health Corporation (NYSE: EHC) an intriguing proposition. With a market capitalization of $12.76 billion, this Birmingham,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds